This newly discovered MAP4Ks-HDAC6-TUBA4A-RANGAP1 pathway is largely not tied to major ALS-causing mutations, suggesting its potential for broad therapeutic applications. This evidence concerns the gene TUBA4A and amyotrophic lateral sclerosis.